Product Information

IBUPROFEN 600 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0466 per EA under NDC 64380080807. Its NADAC has been published 416 times since Sep 5, 2018.

FDA first approved this application on Feb 5, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 600 MG TABLET

Ibuprofen
$0.0466per EA

Strength

600 mg/1

NDC

64380080807

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA078329

FDA Approved

2/5/2009

TE Code

AB

On Market Since

8/24/2018

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 600 MG TABLET has been published 416 times since Sep 5, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0466 per EA
All-time high$0.0687 (Mar 11, 2020)
All-time low$0.0428 (Jul 17, 2024)
52-week high$0.0494
52-week low$0.0428
Median price$0.0560
Average price$0.0556
Largest weekly change+21.4% (Aug 21, 2024)
Weeks tracked416
Tracking sinceSep 5, 2018

Price History

1W

+6.0%

1M

+5.1%

3M

+5.1%

6M

+8.1%

1Y

-5.8%

3Y

-15.2%

5Y

-25.4%

All

-0.7%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of IBUPROFEN 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 600 MG TABLET, manufactured by Strides Pharma Inc., is $0.0466 per EA (NDC 64380080807), effective Aug 19, 2026.

How has the price of IBUPROFEN 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 600 MG TABLET has held within roughly two percent of its current level. It has been tracked across 416 weekly CMS publications since Sep 5, 2018.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 600 MG TABLET?

Since Sep 5, 2018, the NADAC for IBUPROFEN 600 MG TABLET has ranged from a low of $0.0428 (Jul 17, 2024) to a high of $0.0687 (Mar 11, 2020), with a median of $0.0560 per EA.

Are there cheaper alternatives to IBUPROFEN 600 MG TABLET?

Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 600 MG TABLET, is $0.0443 per EA — about 5% below IBUPROFEN 600 MG TABLET.

Who manufactures IBUPROFEN 600 MG TABLET?

IBUPROFEN 600 MG TABLET (NDC 64380080807) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.